- Home
- CSBR vs VERI Comparison
CSBR vs VERI Comparison
Compare CSBR & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSBR | VERI |
|---|---|---|
| Founded | 1985 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.4M | 57.7M |
| IPO Year | 2015 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CSBR | VERI |
|---|---|---|
| Price | $4.78 | $0.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 7.0K | ★ 2.0M |
| Earning Date | 12-14-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,900,000.00 | ★ $92,637,000.00 |
| Revenue This Year | $9.83 | $11.05 |
| Revenue Next Year | $8.50 | $33.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.59 | $0.45 |
| 52 Week High | $8.31 | $6.13 |
Technical Indicators
Market Signals| Indicator | CSBR | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 33.24 |
| Support Level | N/A | N/A |
| Resistance Level | $5.17 | $0.67 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 10.18 | 2.22 |
Price Performance
Historical ComparisonAbout CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.